By Sophie Sassard and Ben Hirschler LONDON, Oct 14 (Reuters) - GlaxoSmithKline is seeking binding bids by next month for a range of older drugs worth more than $3 billion, which it is likely to sell by geographical region, according to people with direct knowledge of the process. Pote
Read more** Biotech company Bavarian Nordic's shares up 8.6 pct to three-and-a-half year highs. ** Its MVA technology, which can be used to improve Ebola vaccines developed by GlaxoSmithKline and Johnson & Johnson, could foster a biodefence business for the company's segment that could become as big
Read moreAmino Technologies: Northland Capital upgrades to buy with a target price of 100p. Anglo American: Canaccord Genuity initiates with a target price of 1720p and a buy recommendation. Credit Suisse upgrades to outperform with a target price of 1800p. Associated British Foods: Societe Generale upgrade
Read more(Adds details) JOHANNESBURG, Oct 9 (Reuters) - South Africa generic drugmaker Aspen Pharmacare Holdings Ltd has teamed up with shareholder GlaxoSmithKline Plc (GSK) to extend its presence in Japan, a lucrative market for low-cost medicines, it said on Thursday. Politicians in the worl
Read more